Document Detail

A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities.
MedLine Citation:
PMID:  20456549     Owner:  NLM     Status:  In-Process    
BACKGROUND: Superficial basal cell carcinoma (sBCC) and Bowen's disease (BD) are usually slow-growing, low-grade malignancies that mainly affect older persons. Surgery is often the first choice of treatment and the modality with the lowest failure rate. However, non-invasive procedures, such as topical methyl aminolevulinate photodynamic therapy (MAL-PDT) and imiquimod, are increasingly demanded by dermatologists and patients, because of their generally favourable efficacy and adverse effects profile and their excellent cosmetic outcome.
OBJECTIVE: To assess the cost of MAL-PDT and of treatment with imiquimod for primary non-melanoma superficial cutaneous carcinomas compared with conventional surgery, thereby calculating the total medical cost, and the direct and indirect costs.
SETTING: We collected data on 67 patients with 86 tumours (32 sBCC, 54 BD). Patients were treated between May 2006 and April 2007 at the Dermatology Department of the Costa del Sol Hospital in Marbella, Spain. The mean cost and mean cost per complete clinical response were calculated for each therapeutic option.
RESULTS: After 2 years of follow-up, a complete response was observed in 89.5% of the MAL-PDT group, 87.5% of the imiquimod group and 97.5% of the surgery group. The difference in costs when compared with the surgery group was a mean saving per lesion treated of 307 euros for the imiquimod group, and 322 euros for the MAL-PDT group.
CONCLUSIONS: Although surgery proved to be more effective treatment, our results suggest that its average cost is greater than that of non-invasive therapy for the treatment of non-melanoma superficial cutaneous carcinomas on the lower limbs, at least after the first 2 years of follow-up.
M Aguilar; M de Troya; L Martin; N Benítez; M González
Related Documents :
20926319 - Costs associated with angiogenesis inhibitor therapies for metastatic renal cell carcin...
11353959 - Advantages of laparoscopic resection for ileocolic crohn's disease. improved outcomes a...
20818839 - Treatment of advanced parkinson's disease in the united states: a cost-utility model.
16877479 - Efficacy of phototherapy for neonatal jaundice is increased by the use of low-cost whit...
20202239 - To circ or not to circ: clinical and pharmacoeconomic outcomes of a prospective trial o...
17911509 - Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomec...
24642149 - Polyacrylamide hydrogel (bulkamid®) in female patients of 80 or more years with urinar...
8068879 - Probability of thrombosis of vascular access among hemodialysis patients treated with r...
19715869 - Prophylactic therapy with valgancyclovir in high-risk (cytomegalovirus d+/r-) liver tra...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the European Academy of Dermatology and Venereology : JEADV     Volume:  24     ISSN:  1468-3083     ISO Abbreviation:  J Eur Acad Dermatol Venereol     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-09     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9216037     Medline TA:  J Eur Acad Dermatol Venereol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1431-6     Citation Subset:  IM    
Copyright Information:
© 2010 The Authors. Journal compilation © 2010 European Academy of Dermatology and Venereology.
Department of Dermatology, Hospital Costa del Sol, Marbella, España.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  On the development of the European S3 guidelines on the systemic treatment of psoriasis vulgaris: st...
Next Document:  Allergic characteristics of urban schoolchildren with atopic eczema in Ghana.